The "Pyelonephritis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of the Pyelonephritis ...

The "Burkitt Lymphoma - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Burkitt Lymphoma Clinical trials ...

The "Meningitis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides an overview of Meningitis Clinical trials scenario. This ...

Men are underrepresented in health research, particularly lifestyle change trials. This study explores why, revealing ...

DelveInsight's Report covers around 60+ products under different phases of clinical development like ... Loxo Oncology, Janssen Research & Development, LLC, TG therapeutics, AFA Insurance ...

Agreement Reached on Primary Endpoint and Phase 3 Trial DesignOral APX3330 is a Late-Stage Clinical Asset Available for PartneringFARMINGTON ...

“Given that IMP-761 is potentially addressing the root cause of many different autoimmune ... Neuren has completed a phase II ...

Patient screening underway; first patient expected to be randomized into the study in JanuaryA leading clinical trial site management ...

Topline Clinical Data Demonstrates Activity of SOR102 Across Multiple Clinical Endpoints Supporting Advancement to Phase 2 Development SALT LAKE CITY, UT, USA I 19, 2024 I Sorriso Pharmaceuticals, a ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel ther ...

Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.